Skip to content

Exercise in Hypoxia and Nitrate Supplementation in Athletes: is the Whole Greater Than the Sum of Its Parts?

Exercise in Hypoxia and Nitrate Supplementation in Athletes: is the Whole Greater Than the Sum of Its Parts?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06727656
Enrollment
30
Registered
2024-12-11
Start date
2019-02-01
Completion date
2020-07-22
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia

Brief summary

Determine the combined effect of training in hypoxia and nitrate supplementation on the performance and health of athletes at sea-level and altitude conditions.

Detailed description

Determine the combined effect of training in hypoxia and nitrate supplementation on the performance and health of athletes at sea-level and altitude conditions. It is hypothesized that the combined effect of these interventions will promote an additional performance and health improvement in this population at sea-level and altitude conditions, compared with the single effect.

Interventions

COMBINATION_PRODUCTNitrate + Hypoxia

The combined effect of nitrate supplementation and hypoxia training on both performance and health at sea-level and altitude conditions.

DIETARY_SUPPLEMENTPlacebo + Hypoxia

The combined effect of placebo supplementation and hypoxia training on both performance and health at sea-level and altitude conditions.

OTHERControl

The combined effect of placebo supplementation and normoxia training on both performance and health at sea-level and altitude conditions.

Sponsors

University of Trás-os-Montes and Alto Douro
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* trained male subjects, regularly involved in competitive running, cycling and/ or triathlon events (4-5 times per week) in the past five years

Exclusion criteria

* smoking or other chronic issues * using medication or dietary supplements in the last 3 months, or during the duration of the study * being exposed to altitude (≥2000 m) in the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Performance adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)Time-to-task failure (time sustained)
Cardiovascular and neuromuscular adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)Maximal oxygen uptake (VO2max: absolute and relative value)
Skeletal muscle adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)Oxidative enzyme activity (cytochrome oxidase subunit IV), citrate synthase, transcription factors (HIF-1alpha and PGC-1alpha) and GLUT4 - assessed through standard enzymatic fluorometric assay and western bllotting
Haematological adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)Blood pressure (Hmmg), mean arterial pressure (calculated as 1/3 \* systolic pressure + 2/3 \* diastolic pressure)
Oxidative stress and antioxidant markers adaptationsMoment #1 (48hours pre-intervention) and moment #2 (48hours post-intervention)Nitrotyrosine, malondialdehyde, ferric-reducing antioxidant power and superoxide dismutase concentrations - all assays on plasma sample analysed by spectrophometry

Secondary

MeasureTime frameDescription
Sleep and cardiac autonomic activity adaptationsMoment #1 (2 weeks pre-intervention - baseline) and moment #2 (4 weeks intervention)Sleep duration (minutes)

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026